{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T23:44:19Z","timestamp":1709250259146},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,7]]},"DOI":"10.7759\/cureus.32281","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T10:02:18Z","timestamp":1670407338000},"source":"Crossref","is-referenced-by-count":1,"title":["Acute Decompensated Heart Failure Due to Combined Ischemic Cardiomyopathy and Cardiac Amyloidosis"],"prefix":"10.7759","author":[{"given":"Arinze N","family":"Bosah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amel","family":"Tobaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kushani","family":"Gajjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kartikeya","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Alpert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2020.09.026","article-title":"Comparison of patterns of coronary artery disease in patients with heart failure by cardiac amyloidosis status","volume":"27","author":"Beyene SS","year":"2021","unstructured":"Beyene SS, Yacob O, Melaku GD, et al.. Comparison of patterns of coronary artery disease in patients with heart failure by cardiac amyloidosis status. Cardiovasc Revasc Med. 2021, 27:31-5. 10.1016\/j.carrev.2020.09.026","journal-title":"Cardiovasc Revasc Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz MA","year":"2015","unstructured":"Gertz MA, Benson MD, Dyck PJ, et al.. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015, 66:2451-66. 10.1016\/j.jacc.2015.09.075","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002558","article-title":"Transthyretin cardiac amyloidosis in Black Americans","volume":"9","author":"Shah KB","year":"2016","unstructured":"Shah KB, Mankad AK, Castano A, Akinboboye OO, Duncan PB, Fergus IV, Maurer MS. Transthyretin cardiac amyloidosis in Black Americans. Circ Heart Fail. 2016, 9:e002558. 10.1161\/CIRCHEARTFAILURE.115.002558","journal-title":"Circ Heart Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi OK","year":"2018","unstructured":"Siddiqi OK, Ruberg FL. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc Med. 2018, 28:10-21. 10.1016\/j.tcm.2017.07.004","journal-title":"Trends Cardiovasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092322","article-title":"Inflammatory and molecular pathways in heart failure-ischemia, HFpEF and transthyretin cardiac amyloidosis","volume":"20","author":"Michels da Silva D","year":"2019","unstructured":"Michels da Silva D, Langer H, Graf T. Inflammatory and molecular pathways in heart failure-ischemia, HFpEF and transthyretin cardiac amyloidosis. Int J Mol Sci. 2019, 20:10.3390\/ijms20092322","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-019-01644-9","article-title":"Coexistence of cardiac amyloidosis with coronary artery disease and the challenges in medical management","volume":"26","author":"Singh V","year":"2019","unstructured":"Singh V, Tiemeier A, Malhotra S. Coexistence of cardiac amyloidosis with coronary artery disease and the challenges in medical management. J Nucl Cardiol. 2019, 26:790-6. 10.1007\/s12350-019-01644-9","journal-title":"J Nucl Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jocs.14985","article-title":"Coronary revascularisation in cardiac amyloidosis","volume":"35","author":"Smith A","year":"2020","unstructured":"Smith A, Edlin J, Hinds C, Ambekar S. Coronary revascularisation in cardiac amyloidosis. J Card Surg. 2020, 35:3248-50. 10.1111\/jocs.14985","journal-title":"J Card Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/96943-acute-decompensated-heart-failure-due-to-combined-ischemic-cardiomyopathy-and-cardiac-amyloidosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:28Z","timestamp":1707507868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/96943-acute-decompensated-heart-failure-due-to-combined-ischemic-cardiomyopathy-and-cardiac-amyloidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.32281","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,7]]}}}